Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03098394 · ClinicalTrials.gov registry record · NA
Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections
A NA study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT03098394 is a NA study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 64 participants.
The verdict
NCT03098394, a NA study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of utilizing a rapid turnaround CT/NG test on treatment of female patients in the emergency department or urgent care setting with possible STIs.
Interventions
- DEVICE Cepheid Xpert CT/NG Rapid Turnaround Test
- DEVICE Polymerase chain reaction (PCR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2023-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03098394
The ClinicalTrials.gov registry entry for NCT03098394 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cepheid Xpert CT/NG Rapid Turnaround Test is the first listed.
NCT03098394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03098394 about?
NCT03098394 is a clinical study titled "Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections". The purpose of this study is to evaluate the effect of utilizing a rapid turnaround CT/NG test on treatment of female patients in the emergency department or urgent care setting with possible STIs.
What is the current status of trial NCT03098394?
This trial is currently terminated. It is a NA study. The enrollment target is 64 participants. The study started on 2018-09-24. Estimated completion is 2023-06-20.
What interventions are being tested in trial NCT03098394?
The interventions under investigation include: Cepheid Xpert CT/NG Rapid Turnaround Test (DEVICE), Polymerase chain reaction (PCR) (DEVICE).
Who is sponsoring clinical trial NCT03098394?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.